Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for messenger RNA and CR...
Saved in:
Published in: | Nature biotechnology Vol. 41; no. 10; pp. 1410 - 1415 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
New York
Nature Publishing Group US
01-10-2023
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for messenger RNA and CRISPR–Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.
A high-throughput screen improves lipid nanoparticle delivery of gene editors in the lung. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions B.L., R.S.M. and S.L. conceived the project and wrote the manuscript with input from all the authors. B.L. and R.S.M. designed the combinatorial lipid library. B.L., R.S.M., S.L., A.G., and A. J. performed experiments and analyzed data. B.L., R.S.M., and S.L. wrote the manuscript. B.L., S.L., A.V., W.X. and D.G.A. discussed the results and edited the manuscript. G.G., R.L., W.X. and D.G.A. acquired funding and supervised the project. |
ISSN: | 1087-0156 1546-1696 |
DOI: | 10.1038/s41587-023-01679-x |